Nausea & Vomiting | Small Cell Lung Cancer | Food Safety Video, 07/02/2024

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
New from NCI
Nausea and Vomiting and Cancer Treatment
male discusses pill bottle with health care professional   Nausea and vomiting may be side effects of cancer treatment and symptoms of some cancers. This new page explains what causes nausea and vomiting and how you can get relief.

Read More
Immunotherapy Extends Lives of People with Early-Stage Small Cell Lung Cancer
drawing of one tumor in one lung, called limited stage, and tumors in both lungs plus brain, spine, and liver, called extensive stage   The immunotherapy drug durvalumab (Imfinzi) can help people with early-stage small cell lung cancer live longer, results from a large clinical trial show. Durvalumab is a type of immunotherapy called an immune checkpoint inhibitor.

Read More
Video: Food Safety for People with Cancer

Some cancer treatments make it easier for you to get sick from contaminated food. This video shares eight tips that can help you properly handle and prepare food to reduce your risk of foodborne illness.

Watch the Video

Surgery to Reduce the Risk of Breast Cancer

This updated page explains the types of surgery that are used to reduce the risk of breast cancer in people who are at very high risk. It also describes those most likely to benefit from surgery, potential harms of the surgeries, and ways to reduce risk that don’t involve surgery.

Read More

Lymphedema and Cancer Treatment
anatomical illustration of the lymphatic system show how lymph vessels are found throughout the body   Lymphedema is swelling caused by a buildup of lymph fluid in the body between the skin and muscle. This new page explains symptoms to watch for and ways you can manage.

Read More
Five-Drug Combination Targets Aggressive B-Cell Lymphomas

NCI researchers have developed a non-chemotherapy treatment regimen for some people with aggressive B-cell lymphoma that has come back or is no longer responding to standard treatments. More than half of clinical trial participants treated with the regimen, called ViPOR, saw their tumors shrink, including some who had full remissions.

Read More

Contact Us
Cancer Information Specialist talks on a headset   Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. This page tells you how to reach us by phone, chat, or email.